fda announcement semaglutide OneSource Receives Approval for Generic Ozempic Injection | OneSource posted on the topic FDA Approves Oral Semaglutide: First

This is something we counsel patients about upfront. Ozempic Could Treat Kidney Disease In addition to semaglutides use for treating diabetes and weight loss, it may also benefit the kidneys

Consult your primary healthcare practitioner if considering a DHEA supplement to determine its suitability and dosage

The Precision Peptide Genetic Test ($99 add-on) analyzes 14 metabolic pathways and identifies genetic variants affecting your response to GLP-1 signaling, inflammation patterns, and gastrointestinal sensitivity

"Our Retatrutide program is being built like a journal-grade methods paper, with explicit hypotheses about stability, solvent behavior, and receptor-relevant assay design that we will test across multiple analytical platforms and publish as structured research briefs." Retatrutide as a model system for multi-receptor incretin biology Retatrutide has attracted sustained interest within the scientific community because it targets multiple incretin and glucagon-related receptors, making it a tractable probe for studying how integrated endocrine signals reshape energy balance, nutrient handling, and downstream metabolic networks

According to the company, these resources include personalized wellness plans and ongoing guidance

Dehydration and acute kidney injury (AKI): Nausea, vomiting, and reduced fluid intake during dose escalation may lead to dehydration